Department of Cardiology, Hospital Italiano de Buenos Aires, Perón 4190, C1199ABB, Ciudad Autónoma de Buenos Aires, Argentina.
Argentine Group for the Study of Lp(a) [GAELp(a)], Buenos Aires, Argentina.
High Blood Press Cardiovasc Prev. 2024 Jul;31(4):381-388. doi: 10.1007/s40292-024-00649-x. Epub 2024 May 13.
A new cardiovascular risk (CVR) calculator that incorporates Lipoprotein(a) [Lp(a)] levels has recently been designed.
To estimate CVR using the new score and to identify the reduction in low-density lipoprotein cholesterol (LDL-C) or systolic blood pressure (SBP) necessary to balance the risk attributable to Lp(a).
CVR throughout life and at 10 years was estimated with the new score in patients in primary prevention, both considering and not considering the value of Lp(a). When the estimated risk considering Lp(a) levels exceeded the baseline risk, the reduction in LDL-C levels or SBP necessary to balance the risk attributable to Lp(a) was calculated.
In total, 671 patients (mean age 54.2 years, 47.2% women) were included. Globally, 22.7% of the population had high Lp(a) values (> 50 mg/dL or > 125 nmol/L). When calculating CVR throughout life and considering the Lp(a) value, the global risk increased in 66.7% of cases (median 19.3%). Similar results were observed when we assessed the 10-year risk. The risk associated with Lp(a) could be completely compensated by decreasing LDL-C (average 21 mg/dL) or SBP (average 6.3 mmHg) in 79.2% and 74.7% of cases, respectively.
When calculating the CVR with the new score, two-thirds and one-third of the population were bidirectionally recategorized as 'up' or 'down,' respectively. The decrease in LDL-C or SBP mitigated the increased risk caused by Lp(a) levels across a substantial proportion of patients.
最近设计了一种新的心血管风险(CVR)计算器,该计算器纳入了脂蛋白(a)[Lp(a)]水平。
使用新评分估算 CVR,并确定降低低密度脂蛋白胆固醇(LDL-C)或收缩压(SBP)以平衡 Lp(a)归因风险所需的幅度。
在初级预防中,考虑和不考虑 Lp(a)值,使用新评分估算终生和 10 年的 CVR。当考虑 Lp(a)水平的估计风险超过基线风险时,计算降低 LDL-C 水平或 SBP 以平衡 Lp(a)归因风险所需的幅度。
共纳入 671 例患者(平均年龄 54.2 岁,47.2%为女性)。总体而言,22.7%的人群 Lp(a)值较高(>50mg/dL 或>125nmol/L)。在计算终生 CVR 并考虑 Lp(a)值时,66.7%的病例(中位数 19.3%)的总体风险增加。当评估 10 年风险时,也观察到了类似的结果。通过降低 LDL-C(平均 21mg/dL)或 SBP(平均 6.3mmHg),可以分别在 79.2%和 74.7%的病例中完全补偿与 Lp(a)相关的风险。
使用新评分计算 CVR 时,三分之二和三分之一的人群分别双向重新分类为“升高”或“降低”。在相当一部分患者中,降低 LDL-C 或 SBP 减轻了 Lp(a)水平升高引起的风险增加。